NCT06784063

Visual Performance With Clareon® Vivity® Intraocular Lenses (IOLs)

Evaluation of the Impact of Residual Astigmatism on the Visual Performance With Clareon Vivity

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 40 (actual)
• Sponsor: Alcon Research · Industry
• Sex: All
• Age: 22 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to generate clinical data to quantify the impact of residual astigmatism on the overall visual performance during distance, intermediate, and near viewing in patients implanted with Clareon Vivity IOLs.

Detailed description

This single visit study is designed to help understand how vision is affected if the eye still has astigmatism after cataract surgery. Participants will be individuals who have already undergone cataract surgery and received a Clareon Vivity IOL in both eyes at least 4 months prior to study enrollment. During the study visit, trial lenses (glass lenses that are used during an eye exam) will be used to temporarily create the effect of astigmatism on the eye.

Conditions

• Astigmatism

Interventions

Type	Name	Description
DEVICE	Clareon Vivity Extended Vision IOL	Extended vision intraocular lens implanted in the capsular bag of the eye during cataract surgery. IOLs are intended for long term use over the lifetime of the cataract patient.

Timeline

• Start date: 2025-04-10
• Primary completion: 2025-06-13
• Completion: 2025-06-13
• First posted: 2025-01-20
• Last updated: 2025-07-20

Locations

3 sites across 1 country: United States

Regulatory

• FDA-regulated device study